In mice with high-risk neuroblastoma, tumors disappeared in response to a new combination treatment with precision medicines, a recent study from University of Gothenburg researchers shows. This is a vital step toward a potentially curative treatment for a form of cancer affecting young children that is currently difficult to treat.

The National Cancer Institute has awarded Mount Sinai researchers $3.15 million in grant funding to assess the potential of a multidisciplinary drug development platform to identify new biological targets for precision-based therapeutics for hepatocellular carcinoma (HCC). The platform includes precision mouse models, tumor 3D organoids, and a proprietary library of small molecule inhibitors.

The German Research Foundation (DFG) has approved the establishment of a new Collaborative Research Center (CRC) in the field of materials science, in which Johannes Gutenberg University Mainz (JGU) is participating with a pioneering subproject. In addition, the existing CRC 1292 coordinated by JGU was approved for a further funding period of four years.

The reason some people get COVID-19, face hospitalization and die may have more to do with underlying health conditions, where they were born, live and work, and their access to testing and care, according to a new Rutgers study.

New research by RCSI University of Medicine and Health Sciences suggests that effective wound healing may be aided by replicating a crucial component of our blood.